4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-223955
CEO & President sold 3,311 shares at $18.36 ($60,790)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-13 | Sale : show line 1 in the form 10b5-1 | −3,311 | $18.36 | $60,790 | 370,834 | D |
| Open-market sales · 3,311 sh · avg $18.36 · $60,790 | ||||||
Loading xslF345X06/ownership.xml…